Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema

Eye

Volumn 19, Issue 6, 2005, Pages 686-688

  Bakri, S J ^a,b   Shah, A ^a   Falk, N S ^a   Beer, P M ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYL ALCOHOL; DISODIUM HYDROGEN PHOSPHATE; MACROGOL; POLYSORBATE 80; PRESERVATIVE; SODIUM CHLORIDE; SODIUM DIHYDROGEN PHOSPHATE; TRIAMCINOLONE ACETONIDE;

ANTERIOR EYE CHAMBER; ARTICLE; CLINICAL ARTICLE; DRUG DOSE REGIMEN; DRUG FORMULATION; ENDOPHTHALMITIS; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MEDICAL RECORD; OPTICAL COHERENCE TOMOGRAPHY; RETINA BLOOD VESSEL OCCLUSION; RETINA DETACHMENT; RETINA MACULA EDEMA; RETINA MACULA LUTEA; SHELF LIFE; STATISTICAL SIGNIFICANCE; VISUAL ACUITY;

EID: 21244445737     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6701602     Document Type: Article

References (15)

1. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E. Intravitreal triamcinolone acetonide for macular ooedema due to central retinal vein occlusion. Br J Ophthalmol 2002; 86(2): 247-248.
2. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E et al. Intravitreal triamcinolone for refractory diabetic macular oedema. Ophthalmology 2002; 109(5): 920-927.
3. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J. Intravitreal triamcinolone for uveitic cystoid macular oedema: an optical coherence tomography study. Ophthalmology 2001; 108(4): 765-772.
4. Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003; 136(5): 791-796.
5. Nelson ML, Tennant MT, Sivalingam A, Regillo CD, Belmont JB, Martidis A. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 2003; 23(5): 686-691.
6. Benz MS, Murray TG, Dubovy SR, Katz RS, Eifrig CW. Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophthalmol 2003; 121(2): 271-273.
7. Sutter FK, Gillies MC. Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol 2003; 87(8): 972-974.
8. Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudhry NA. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol. 2003; 121(9): 1279-1282.
9. Moshfeghi DM, Kaiser PK, Bakri SJ, Scott IU, Sears JE, Benz M et al. Sterile endophthalmitis following intravitreal triamcinolone acetonide injection. Ophthalmic Surg Lasers Imaging, Submitted for publication.
10. Walter P, Luke C, Sickel W. Antibiotics and light responses in superfused bovine retina. Cell Mol Neurobiol 1999; 19(1): 87-92.
11. Hida T, Chandler D, Arena JE, Machemer R. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 1986; 101(2): 190-195.
12. Craig DB, Habib GG. Flaccid paraparesis following obstetrical epidural anesthesia: possible role of benzyl alcohol. Anesth Analg 1977; 56(2): 219-221.
13. Burk SE, Da Mata AP, Snyder ME, Schneider S, Osher RH, Cionni RJ. Visualizing vitreous using Kenalog suspension. J Cataract Refract Surg 2003; 29(4): 645-651.
14. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters III GB, Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003; 110(4): 681-686.
15. Bakri SJ, Beer PM. The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging 2003; 34: 386-390.